Trials / Recruiting
RecruitingNCT05486546
Contoura With Phorcides Compared to Wavefront Optimized LASIK
Comparison of Visual Acuity and Quality of Life Following Contoura With Phorcides Compared to WaveLight Wavefront Optimized LASIK
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Daniel Terveen · Academic / Other
- Sex
- All
- Age
- 21 Years – 38 Years
- Healthy volunteers
- Not accepted
Summary
Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Contoura with Phorcides | Participants that undergo LASIK surgery using Contoura with Phorcides Analytic Engine |
| DEVICE | WaveLight Wavefront Optimized | Participants that undergo LASIK surgery using WaveLight Wavefront Optimized |
Timeline
- Start date
- 2022-08-15
- Primary completion
- 2023-09-01
- Completion
- 2023-12-01
- First posted
- 2022-08-03
- Last updated
- 2023-04-26
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05486546. Inclusion in this directory is not an endorsement.